L-365,260

Modify Date: 2025-08-25 23:19:48

L-365,260 Structure
L-365,260 structure
Common Name L-365,260
CAS Number 118101-09-0 Molecular Weight 398.45700
Density 1.23g/cm3 Boiling Point 611.5ºC at 760 mmHg
Molecular Formula C24H22N4O2 Melting Point N/A
MSDS Chinese USA Flash Point 323.6ºC
Symbol GHS06 GHS09
GHS06, GHS09
Signal Word Danger

 Use of L-365,260


L-365260 is a potent and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with Kis of 1.9 nM and 2.0 nM, respectively. L-365260 interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors. L-365260 can enhance Morphine analgesia and prevents Morphine tolerance[1][2][3].

 Names

Name N-[(3R)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N′-(3-methylphenyl)-urea
Synonym More Synonyms

 L-365,260 Biological Activity

Description L-365260 is a potent and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with Kis of 1.9 nM and 2.0 nM, respectively. L-365260 interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors. L-365260 can enhance Morphine analgesia and prevents Morphine tolerance[1][2][3].
Related Catalog
Target

Ki: 1.9 nM (gastrin); 2.0 nM (CCK-B)[1]

In Vitro L-365260 (1 μM) strongly attenuates the CCK8S- and CCK4-mediated depolarization in a different neuron[2]. L-365260 exhibits a similar high affinity for brain CCK-B receptors of rats, mice and man, and a lower affinity for gastrin and brain CCK-B (IC50=20-40 nM) receptors in dog tissues[1].
In Vivo L-365260 (0.01-10 mg/kg; s.c.) enhances analgesia induced by a submaximal dose of Morphine (4 mg/kg) in rats[3]. L-365260 (0.2 mg/kg; s.c. twice daily for 5 days) significantly prolongs the duration of Morphine analgesia in rats[3]. L-365260 (0.1-30 mg/kg; p.o.) antagonizes gastrin-stimulated acid secretion in mice (ED50=0.03 mg/kg), rats (ED50=0.9 mg/kg) and guinea pigs (ED50=5.1 mg/kg)[1]. Animal Model: Male Sprague-Dawley rats (300-350 g) were injected with Morphine[3] Dosage: 0.01, 0.05, 0.1, 0.2, 0.75, 1.0, 10.0 mg/kg Administration: S.c. 10 min prior to i.p. injection of 4 mg/kg Morphine Result: Enhanced morphine analgesia.
References

[1]. Lotti VJ, et, al. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol. 1989 Mar 21;162(2):273-80.

[2]. Chung L, et, al. Cholecystokinin action on layer 6b neurons in somatosensory cortex. Brain Res. 2009 Jul 28;1282:10-9.

[3]. Dourish CT, et, al. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur J Pharmacol. 1990 Jan 25;176(1):35-44.

 Chemical & Physical Properties

Density 1.23g/cm3
Boiling Point 611.5ºC at 760 mmHg
Molecular Formula C24H22N4O2
Molecular Weight 398.45700
Flash Point 323.6ºC
Exact Mass 398.17400
PSA 73.80000
LogP 3.92110
Vapour Pressure 6.85E-15mmHg at 25°C
Index of Refraction 1.648
Storage condition 2-8°C

 Safety Information

Symbol GHS06 GHS09
GHS06, GHS09
Signal Word Danger
Hazard Statements H301-H400
Precautionary Statements P273-P301 + P310
RIDADR UN2811 - class 6.1 - PG 3 - EHS - Toxic solids, organic, n.o.s., HI: all

 Articles25

More Articles
Combination pharmacotherapy for the treatment of neuropathic pain in adults.

Cochrane Database Syst. Rev. 7 , CD008943, (2012)

Pharmacotherapy remains an important modality for the treatment of neuropathic pain. However, as monotherapy current drugs are associated with limited efficacy and dose-related side effects. Combining...

Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.

J. Med. Chem. 48(1) , 180-91, (2005)

The Cholecystokinin-1 receptor (CCK1R) mediates actions of CCK in areas of the central nervous system and of the gut. It is a potential target to treat a number of diseases. As for all G-protein-coupl...

A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

Br. J. Pharmacol. 154(5) , 1009-15, (2008)

Leptin regulates energy expenditure and body weight by acting both on the hypothalamus and on peripheral targets. Central actions of leptin are enhanced by cholecystokinin (CCK). The interaction betwe...

 Synonyms

L-365,260,N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea
L-365260
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

L-365,260 suppliers

L-365,260 price

Related Compounds: More...
Cyclo(L-isoleucyl-D-2,3,4,5-tetrahydro-3-pyridazinecarbonyl-L-2,3,4,5-tetrahydro-3-pyridazinecarbonyl-N-methyl-D-phenylalanyl-L-prolyl-D-phenylalanyl
122211-30-7
4-bromo-N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)benzamide
111035-59-7
L-lysine acetate
52315-76-1
L-arginine monothiazolidine-4-carboxylate
57631-15-9
L-Arginine-L-pyroglutamate
56265-06-6
L-Lysine monoacetate
57282-49-2
L-Metalaxyl
69516-34-3
L-proline sodium salt
210879-16-6
l-Alminoprofen
54362-71-9
3-{N-ethyl-1-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclohexyl]formamido}-2-methylpropanoic acid
2172523-89-4
2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-hydroxy-3-methylpentanoic acid
2156761-29-2
1-{2-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-3-methylbutanoyl}azepane-2-carboxylic acid
2171775-54-3
3-({[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclohexyl]formamido}methyl)pentanoic acid
2171411-60-0
3-(N-ethyl-2-{1-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclobutyl}acetamido)-2-methylpropanoic acid
2172267-70-6
5-({1-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethyl]-1H-1,2,3-triazol-4-yl}formamido)pentanoic acid
2172375-66-3
tert-butyl (2R)-1-(trifluoromethyl)piperidine-2-carboxylate
2137033-35-1
2-{[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]oxy}acetic acid
2172267-82-0
3-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]-2-methylpropanoic acid
2172521-10-5
2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]-2-methylpropanoic acid
2171682-24-7